Literature DB >> 18698478

Design and synthesis of bioactive 1,2-annulated adamantane derivatives.

Grigoris Zoidis1, Andrew Tsotinis, Nicolas Kolocouris, John M Kelly, S Radhika Prathalingam, Lieve Naesens, Erik De Clercq.   

Abstract

Adamantanopyrrolidines 8, 9 and 10, adamantanopyrrolidines 16 and 18, adamantanoxazolone 20, adamantanopyrazolone 23, adamantanopyrazolothione 24 and adamantanocyclopentanamine 32 were synthesized and tested for anti-influenza A virus and trypanocidal activity. The stereoelectronic requirements for optimal antiviral and trypanocidal potency were investigated. Pyrrolidine 16 proved to be the most active of the compounds tested against influenza A virus, being 4-fold more active than amantadine, equipotent to rimantadine and 19-fold more potent than ribavirin. Oxazolone 20 showed significant trypanocidal activity against bloodstream forms of the African trypanosome, Trypanosoma brucei, being approximately 3 times more potent than rimantadine and almost 50-fold more active than amantadine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18698478     DOI: 10.1039/b804907f

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  7 in total

1.  Coexistence of two adamantane binding sites in the influenza A M2 ion channel.

Authors:  Matthew R Rosenberg; Marco G Casarotto
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-19       Impact factor: 11.205

Review 2.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

3.  Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus.

Authors:  María D Duque; Chunlong Ma; Eva Torres; Jun Wang; Lieve Naesens; Jordi Juárez-Jiménez; Pelayo Camps; F Javier Luque; William F DeGrado; Robert A Lamb; Lawrence H Pinto; Santiago Vázquez
Journal:  J Med Chem       Date:  2011-04-05       Impact factor: 7.446

4.  Discovery of spiro-piperidine inhibitors and their modulation of the dynamics of the M2 proton channel from influenza A virus.

Authors:  Jun Wang; Sarah D Cady; Victoria Balannik; Lawrence H Pinto; William F DeGrado; Mei Hong
Journal:  J Am Chem Soc       Date:  2009-06-17       Impact factor: 15.419

5.  Novel lipophilic acetohydroxamic acid derivatives based on conformationally constrained spiro carbocyclic 2,6-diketopiperazine scaffolds with potent trypanocidal activity.

Authors:  Christos Fytas; Grigoris Zoidis; Nikolaos Tzoutzas; Martin C Taylor; George Fytas; John M Kelly
Journal:  J Med Chem       Date:  2011-06-27       Impact factor: 7.446

6.  Synthesis of benzopolycyclic cage amines: NMDA receptor antagonist, trypanocidal and antiviral activities.

Authors:  Eva Torres; María D Duque; Marta López-Querol; Martin C Taylor; Lieve Naesens; Chunlong Ma; Lawrence H Pinto; Francesc X Sureda; John M Kelly; Santiago Vázquez
Journal:  Bioorg Med Chem       Date:  2011-12-02       Impact factor: 3.641

7.  Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.

Authors:  Marcel Kaiser; Pascal Mäser; Leela Pavan Tadoori; Jean-Robert Ioset; Reto Brun
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.